Robeco Institutional Asset Management B.V. trimmed its stake in shares of CVS Health Corporation (NYSE:CVS) by 42.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 280,720 shares of the pharmacy operator’s stock after selling 209,222 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in CVS Health Corporation were worth $22,586,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Horan Capital Advisors LLC. increased its stake in CVS Health Corporation by 3.2% in the 2nd quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after acquiring an additional 1,000 shares during the last quarter. Community Bank N.A. increased its stake in CVS Health Corporation by 7.3% in the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after acquiring an additional 1,362 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in CVS Health Corporation by 3.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after acquiring an additional 5,478 shares during the last quarter. Midwest Investment Management LLC increased its stake in CVS Health Corporation by 6.2% in the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after acquiring an additional 1,245 shares during the last quarter. Finally, Fiduciary Trust Co. increased its stake in CVS Health Corporation by 1.2% in the 1st quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after acquiring an additional 4,265 shares during the last quarter. Institutional investors own 81.64% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Robeco Institutional Asset Management B.V. Has $22.59 Million Position in CVS Health Corporation (CVS)” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.com-unik.info/2017/11/05/robeco-institutional-asset-management-b-v-has-22-59-million-position-in-cvs-health-corporation-cvs.html.
CVS Health Corporation (NYSE:CVS) opened at $69.25 on Friday. CVS Health Corporation has a 52-week low of $68.01 and a 52-week high of $84.72. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.56 and a current ratio of 1.09. The firm has a market capitalization of $70,397.13, a P/E ratio of 11.84, a P/E/G ratio of 1.26 and a beta of 0.86.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company had revenue of $45.69 billion during the quarter, compared to analyst estimates of $45.36 billion. During the same quarter last year, the company earned $1.32 EPS. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. equities analysts forecast that CVS Health Corporation will post 5.88 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Investors of record on Tuesday, October 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.89%. The ex-dividend date of this dividend was Monday, October 23rd. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.
CVS has been the topic of several recent research reports. Royal Bank Of Canada initiated coverage on CVS Health Corporation in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price objective on the stock. Robert W. Baird reiterated a “hold” rating and set a $77.00 price objective on shares of CVS Health Corporation in a research report on Friday, October 27th. Loop Capital initiated coverage on CVS Health Corporation in a research report on Thursday, August 24th. They set a “hold” rating and a $83.00 price objective on the stock. Jefferies Group LLC set a $86.00 price objective on CVS Health Corporation and gave the company a “hold” rating in a research report on Wednesday, October 18th. Finally, Wolfe Research lowered CVS Health Corporation from an “outperform” rating to a “market perform” rating and reduced their price objective for the company from $89.00 to $82.00 in a research report on Monday, August 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $87.33.
In related news, EVP Thomas M. Moriarty sold 90,267 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the completion of the transaction, the executive vice president now owns 70,102 shares of the company’s stock, valued at approximately $5,580,820.22. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Larry J. Merlo sold 241,150 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $83.07, for a total value of $20,032,330.50. Following the transaction, the insider now directly owns 299,255 shares of the company’s stock, valued at approximately $24,859,112.85. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 716,625 shares of company stock valued at $58,318,431. 0.61% of the stock is owned by corporate insiders.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
What are top analysts saying about CVS Health Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CVS Health Corporation and related companies.